Lab Links Bio-Tech Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 26-07-2024
- Paid Up Capital ₹ 2.16 M
as on 26-07-2024
- Company Age 35 Year, 26 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.50 M
as on 26-07-2024
- Satisfied Charges ₹ 7.50 M
as on 26-07-2024
- Revenue -99.99%
(FY 2023)
- Profit 34.39%
(FY 2023)
- Ebitda 96.68%
(FY 2023)
- Net Worth -4.77%
(FY 2023)
- Total Assets -6.37%
(FY 2023)
About Lab Links Bio-Tech
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 2.16 M.
The company currently has active open charges totaling ₹4.50 M. The company has closed loans amounting to ₹7.50 M, as per Ministry of Corporate Affairs (MCA) records.
Ravindranath Gandlur, Uma Gandlur, and Usha Gandlur serve as directors at the Company.
- CIN/LLPIN
U33119KA1989PTC010439
- Company No.
010439
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Oct 1989
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Lab Links Bio-Tech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Usha Gandlur  | Director | 16-Oct-1989 | Current |
| Ravindranath Gandlur | Director | 16-Oct-1989 | Current |
| Uma Gandlur | Director | 16-Oct-1989 | Current |
Financial Performance and Corporate Structure Insights of Lab Links Bio-Tech.
Lab Links Bio-Tech Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 99.99% decrease. The company also saw a substantial improvement in profitability, with a 34.39% increase in profit. The company's net worth dipped by a decrease of 4.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lab Links Bio-Tech?
In 2023, Lab Links Bio-Tech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Ministry Of Science And Technology Creation Date: 02 Jan 2013 | ₹4.50 M | Open |
State Bank Of Mysore Creation Date: 30 Aug 2010 | ₹7.50 M | Satisfied |
How Many Employees Work at Lab Links Bio-Tech?
Unlock and access historical data on people associated with Lab Links Bio-Tech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lab Links Bio-Tech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lab Links Bio-Tech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
